Transcriptional effects of 177Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude mice

Transcriptional effects of 177Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude mice

Abstract Background 177Lu-octreotate is used for therapy of somatostatin receptor expressing neuroendocrine tumors with promising results, although complete tumor remission is rarely seen. Previous studies on nude mice bearing the human small intestine neuroendocrine tumor, GOT1, have shown that a p...

Full description

Bibliographic Details
Main Authors: Johan Spetz, Britta Langen, Nils-Petter Rudqvist, Toshima Z. Parris, Emman Shubbar, Johanna Dalmo, Bo Wängberg, Ola Nilsson, Khalil Helou, Eva Forssell-Aronsson
Format: Article
Language:English
Published: SpringerOpen 2019-03-01
Series:EJNMMI Research
Subjects:
GEPNET
NET
Radionuclide therapy
Radiation biology
Gene expression
Midgut carcinoid
Online Access:http://link.springer.com/article/10.1186/s13550-019-0500-2

Internet

http://link.springer.com/article/10.1186/s13550-019-0500-2

Similar Items